Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 10016-20-3 | MDL No. : | MFCD00078207 |
Formula : | C36H60O30 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | HFHDHCJBZVLPGP-RWMJIURBSA-N |
M.W : | 972.84 | Pubchem ID : | 444913 |
Synonyms : |
|
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
97% | In pyridine; N,N-dimethyl-formamide at 100℃; for 18h; | |
86% | With pyridine; dmap In N,N-dimethyl-formamide at 100℃; for 18h; | |
75% | With pyridine; dmap In N,N-dimethyl-formamide at 100℃; for 18h; Inert atmosphere; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
73.4% | With pyridine at 20℃; Inert atmosphere; | 1 Example 1: Synthesis of activated cyclodextrins Synthesis of mono-6-deoxy-6-(p-tolylsulfonyl)-a-cyclodextrin (a-CDOTs): p- Toluenesulfonyl chloride (634.0 mg, 2.96 mmol) was added to 50 ml pyridine solution of a- CD (5.0 g, mmol). After stirring overnight at room temperature in N2 atmosphere, the solution was evaporated and recrystallized in cold acetone from water. Alpha-CDOTs was obtained in a yield of 73.4%. The product were tracked by TLC (1-propanol: ethyl acetate: water: ΝΗ32Ο = 3:1 :2: 1 (v/v)) visualized with CAM solution. |
26% | With pyridine for 0.25h; | |
20% |
19.7% | With pyridine for 2h; Ambient temperature; | |
13.5% | Stage #1: alpha cyclodextrin With sodium hydroxide In water for 0.166667h; Stage #2: p-toluenesulfonyl chloride In water; acetonitrile at 20℃; for 2.33333h; | 1.1 6A-O-(p-Toluenesulfonyl)α-CD (2) α-CD (10.0g, 10.3 mmol) was suspended in 20 mL of water, and NaOH (1.23 g, 30.7 mmol) in 3.0 mL of water was added dropwise over 10 min. The suspension became homogeneous after the addition was complete. p-Toluenesulfonyl chloride (1.96 g, 10.3 mmol) in 4.0 mL CH3CN was added dropwise over 20 min. A white precipitate was visible immediately after the start of the addition. The reaction mixture was stirred another 2 h at room temperature and then filtered. The filtrate was acidified to about pH 7-8 with 1N HCl and the product allowed to precipitate at 4 C° overnight. The resulting white precipitate was recovered by suction filtration to provide 3.49 g of crude product. Recrystalize the solid using hot water and dried at 60 °C for 24 h under vacuum to afford 2 (1.57 g) as a white solid in 13.5% yield. Rf = 0.55 (n-BuOH/C2H5OH/H2O = 5:4:3). 1H NMR (400 MHz, D2O): δ 7.98 (d, 2H, J = 8.1 Hz), 7.56 (d, 2H, J = 8.1 Hz), 5.05 - 5.06 (m, 5H), 4.90 (d, 1H, J = 3.0 Hz), 4.42 (dd, 1H, J = 3.0, 10.0 Hz), 4.10 (t, 1H, J = 9.1 Hz), 3.47 - 3.89 (m, 34H); 13C NMR (100 MHz, CDCl3): δ 146.30, 131.60, 130.28, 128.30, 101.80, 101.55, 101.44, 101.33, 98.50, 81.48, 81.37, 81.28, 81.21, 81.14, 78.92, 73.49, 73.41, 73.26, 72.58, 72.20, 72.12, 72.01, 71.95, 71.89, 71.76, 71.64, 71.45, 71.28, 70.06, 60.49, 60.34, 60.24, 60.12, 21.32. |
10% | With pyridine at 20℃; for 0.25h; | 4 [31 ,32,33,34,35,36,37,38,39,40,41,42-Dodecahy- droxy-1 0,1 5,20,25,30-pentakis(hydroxymethyl)-2,4, 7,9,12,14,17,1 9,22,24,27,29-dodecaoxaheptacycloyl]methyl 4-methyl benzene-1-sulfonate (14)2 To a solution of a-cyclodextrin (13, lOg, lOmmol) in dry pyridine (Py) (0.32 L) was added 4-toluenesulfonyl chloride (TsC1) (20 g, 0.10 mol) at room temperature. The mixture was stirred at this temperature for 15 minutes and was quenched with water (60 mE) immediately. The reaction mixture was concentrated under reduce pressure to remove the volatiles (pyridine and water). The residue was purified by reversed phase flash chromatography (0-25% of acetonitrile in water) to give product 14 (1.1 g, 10% yield) as a white solid. ESI mlz: 1127 (M+H). |
With pyridine for 5h; Ambient temperature; | ||
2.1 g | With pyridine for 5h; Ambient temperature; | |
With pyridine | ||
With pyridine at 20℃; | ||
With pyridine at 20℃; | ||
With pyridine regioselective reaction; | ||
In water at 25℃; | ||
With pyridine | ||
With pyridine at 20℃; for 0.0833333h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With iodine; triphenylphosphine In N,N-dimethyl-formamide at 70℃; for 20h; Inert atmosphere; | 11 Example 11; Compound 7 To a solution of triphenylphosphine (16.3 g, 62.1 mmol) and iodine (16.8 g, 66.24 mmol) in dry DMF (80 mL) was added CD (5 g, 4.14 mmol) and the solution was stirred at 70°C during 20 h. It was then concentrated under reduced pressure to about 30 mL and the pH was adjusted to 9 by addition of sodium methoxide in methanol (3M, 30 mL). The solution was kept at room temperature for 30 min, after what it was poured into ice water (20mL/mmol). The precipitate was collected by filtration and washed with methanol to afford 6-deoxy-6- iodo-CDs 6 in a quantitative yield. |
91% | With tetraethylammonium iodide; 4-pyrrolidin-1-ylpyridine; ethanaminium,N-(difluoro-λ4-sulfanylidene)-N-ethyl-,tetrafluoroborate In N,N-dimethyl-formamide at 20℃; regioselective reaction; | Per(6-deoxy-6-halo)cyclodextrins 2; General Procedure General procedure: To a solution of freshly dried cyclodextrin 1 (2 mmol) in anhydrous DMF (40 mL) were added XtalFluor-E (2 equiv per glucose unit),4-(1-pyrrolidino)pyridine (1 equiv per glucose unit) and an anhydrous tetraethylammonium halide (2 equiv per glucose unit) with stirring at r.t. After the reaction was complete, as monitored by TLC, DMF was removed under reduced pressure and the resulting residue was poured into sat. Na2CO3 solution (50 mL); the reaction mixture was stirred for another 1 h. Addition of cold acetone (200mL) gave a precipitate which was collected by filtration and exhaustively washed with H2O and acetone to afford 2 as a white or pale brown solid. |
80% | With Iod; triphenylphosphine In N,N-dimethyl-formamide at 80℃; for 15h; |
80.2% | With iodine; triphenylphosphine In N,N-dimethyl-formamide at 80℃; for 18h; | |
80% | With iodine; triphenylphosphine In N,N-dimethyl-formamide at 70℃; for 19h; Inert atmosphere; | 1.1 (1) Weigh 12.12g of triphenylphosphine and add it to 50mL of DMF, then slowly add 12.27g of iodine under stirring, stir for 0.25h, and then add 3.0g of dry α-cyclodextrin, N2 Protect, stir at 70°C for 19h; after the reaction is finished, spin off 2/3 volume of DMF, then add 3mol/L sodium methoxide methanol solution to quench,Precipitating with acetone and drying to obtain 4g of (6-I)α-cyclodextrin with a yield of 80%; |
75% | With iodine; triphenylphosphine In N,N-dimethyl-formamide at 20℃; | |
71% | With iodine; triphenylphosphine In N,N-dimethyl-formamide at 20℃; Inert atmosphere; | |
66% | With iodine; triphenylphosphine In N,N-dimethyl-formamide at 80℃; Inert atmosphere; | 5.1 Synthesis of hexakis (6-deoxy-6-iodo)-α-CD (2) To a solution of triphenylphosphane (10.38 g/39.6 mmol) and iodine (10.06 g/39.6 mmol) in dry DMF (50 mL) was added α-CD (6 mmol) and the solution was stirred at 80oC overnight. It was then concentrated using a rotary evaporator vacuum (EYELA N-1100DWD, Tokyo Rikakikai, Tokyo, Japan) to about 20 mL and the pH adjusted to 9 by addition of sodium methoxide in methanol (3M). The solution was kept at room temperature for 30 min to destroy the formate esters formed in the reaction, after which it was poured into ice water. The precipitate was collected by filtration and washed with methanol to yield 6-deoxy-6-iodo-α-CD 2. Yield 66%; 1H NMR (400 MHz, DMSO-d6): δ 5.59 (br s, 12H), 4.86-4.93 (m, 6H), 3.79 (br s, 6H), 3.70 (br s, 6H), 3.59 (br s, 6H), 3.50 (d, 6H, J = 7.2 Hz), 3.32 (br s, 12H, overlap with H2O); 13C NMR (100 MHz, DMSO-d6): δ 101.79, 86.29, 72.20, 71.69, 70.63, 9.69; HRMS Calcd for C36H54I6NaO24 [M+Na]+: 1654.7166. Found 1654.7132. |
With methanol; iodine; sodium methylate; triphenylphosphine 1.) DMF, 80 deg C, 18h, 2.) pH 9-10, r.t., 30 min; Yield given. Multistep reaction; | ||
With iodine; triphenylphosphine | ||
With iodine; triphenylphosphine In N,N-dimethyl-formamide at 80℃; | ||
With iodine; triphenylphosphine In N,N-dimethyl-formamide | ||
With iodine; triphenylphosphine In N,N-dimethyl-formamide |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96% | With tetrabutylammomium bromide; (chloro-phenylthio-methylene)dimethylammonium chloride In N,N-dimethyl-formamide at 20℃; regioselective reaction; | |
95% | With tetraethylammonium bromide; 4-pyrrolidin-1-ylpyridine; ethanaminium,N-(difluoro-λ4-sulfanylidene)-N-ethyl-,tetrafluoroborate In N,N-dimethyl-formamide at 20℃; regioselective reaction; | Per(6-deoxy-6-halo)cyclodextrins 2; General Procedure General procedure: To a solution of freshly dried cyclodextrin 1 (2 mmol) in anhydrous DMF (40 mL) were added XtalFluor-E (2 equiv per glucose unit),4-(1-pyrrolidino)pyridine (1 equiv per glucose unit) and an anhydrous tetraethylammonium halide (2 equiv per glucose unit) with stirring at r.t. After the reaction was complete, as monitored by TLC, DMF was removed under reduced pressure and the resulting residue was poured into sat. Na2CO3 solution (50 mL); the reaction mixture was stirred for another 1 h. Addition of cold acetone (200mL) gave a precipitate which was collected by filtration and exhaustively washed with H2O and acetone to afford 2 as a white or pale brown solid. |
86% | With bromine; triphenylphosphine In N,N-dimethyl-formamide at 75 - 80℃; for 18h; |
85% | With bromine; triphenylphosphine In N,N-dimethyl-formamide at 80℃; for 17h; | |
76% | With bromine; triphenylphosphine In N,N-dimethyl-formamide at 70℃; | |
With methanol; bromine; sodium methylate; triphenylphosphine 1.) DMF, 80 deg C, 15 h, 2.) pH 9-10, r.t., 30 min; Yield given. Multistep reaction; | ||
With N-(bromomethylene)-N-methylmethanaminium bromide In N,N-dimethyl-formamide at 80℃; for 18h; Yield given; | ||
With bromomethylenemorpholinium bromide; sodium methylate 1.) DMF, 45 deg C, 2.) methanol; Yield given. Multistep reaction; | ||
With bromine; triphenylphosphine In N,N-dimethyl-formamide at 75 - 80℃; | ||
With N-Bromosuccinimide; triphenylphosphine In N,N-dimethyl-formamide at 60℃; for 4h; | ||
With N-Bromosuccinimide; triphenylphosphine In N,N-dimethyl-formamide | ||
Stage #1: alpha cyclodextrin With N-(bromomethylene)-N-methylmethanaminium bromide In N,N-dimethyl-formamide at 70℃; for 4h; Stage #2: With water at 40℃; for 6h; | ||
372 mg | With N-Bromosuccinimide; triphenylphosphine In N,N-dimethyl-formamide at 90℃; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
83% | With pyridine at 0 - 20℃; | |
80% | With 1H-imidazole In N,N-dimethyl-formamide at 20℃; for 1.5h; | |
77.2% | With pyridine at 20℃; for 12h; |
76% | With pyridine at 20℃; for 24h; | Synthesis of 3 To a solution of α-CD (3.00 g, 3.08 mmol) in dry pyridine (20 ml) was added a solution of ClSiMe2(t-Bu) (8.36 g, 55.4 mmol) in dry pyridine (20 ml) at r.t.. The mixture was allowed to stir at r.t. for 24 h. The resulted precipitates were collected by filtration and then dissolved with ethyl acetate.The organic solution was washed with HCl aq twice and then with water. The organic layer was separated and dried over anhydrous sodium sulfate. Removal of solvent gave 3a (3.88 g, 76 % yield) as white powder. The corresponding 3b was synthesized by the same procedure using β-CD instead of α-CD. |
75% | With 1H-imidazole In N,N-dimethyl-formamide | |
75% | With pyridine at 0 - 20℃; | |
69% | With pyridine for 24h; Ambient temperature; | |
50% | With pyridine Ambient temperature; | |
50% | In pyridine | |
With pyridine | ||
With pyridine; 1H-imidazole at 20℃; for 8h; | ||
With pyridine for 24h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
18% | With lithium azide; carbon tetrabromide; triphenylphosphine In N,N-dimethyl-formamide for 6h; Ambient temperature; Further byproducts given. Yields of byproduct given; | |
18% | With lithium azide; carbon tetrabromide; triphenylphosphine In N,N-dimethyl-formamide for 6h; Ambient temperature; Yield given. Further byproducts given; | |
18% | With lithium azide; carbon tetrabromide; triphenylphosphine In N,N-dimethyl-formamide for 6h; Ambient temperature; Further byproducts given. Title compound not separated from byproducts; |
3.69 g | Stage #1: alpha cyclodextrin With N-Bromosuccinimide; triphenylphosphine In N,N-dimethyl-formamide at 8 - 50℃; for 7.5h; Inert atmosphere; Stage #2: With sodium azide In N,N-dimethyl-formamide at 80℃; for 5h; | Synthesis of 6A,6X-diazido-α-CDs via dibromo-α-CD intermediates6A,6X-Diazido-6A,6X-dideoxy-α-cyclodextrin (4, reaction 3): 6A,6X-Brominated α-CD 5 was prepared according to the modified procedure [3].Triphenylphosphine (36.4 g, 138 mmol) was dissolved in 125 mL of freshly distilledDMF under Ar atmosphere. The solution was cooled down to 8 °C, and NBS wasslowly added to the solution which became dark violet. Dried α-CD (1, 25 g, 25.7mmol) was dissolved in 100 mL of DMF and added in one portion during 20 minutesto the dark violet reaction mixture. The mixture was heated up to 50 °C, and theconversion to dibromo-α-CD was monitored by direct phase TLC (eluent B). After 7.5h the reaction was stopped by addition of 100 mL of MeOH. After 10 minutes ofvigorous stirring, the red-violet reaction mixture was cooled and poured to 1.3 mL ofMeOH (pH 3). Addition of sodium methoxide solution (100 mL) resulted in slowprecipitation (pH 12). The yellowish precipitate was recovered by filtration, washed with MeOH (3 × 300 mL) and dried to constant weight in a vacuum drying box in thepresence of P2O5 and KOH. The white solid (15.27 g), containing unreacted α-CD (1, ≈ 35% based on TLC, Rf =0.15, eluent B), monobromo-α-CD (≈ 35% based on TLC, Rf = 0.25, eluent B),dibromo-α-CD (5, ≈ 20% based on TLC, Rf = 0.35, eluent B) and oversubstitutedproducts (less than 10% based on TLC, Rf = 0.5, eluent B) was dissolved in DMF(300 mL), sodium azide (2.72 g, 42.0 mmol) was added, and the mixture was heatedto 80 °C for 5 h. DMF was removed under reduced pressure at 60 °C and theyellowish residue was poured into acetone (1.3 L) under vigorous stirring. The whiteprecipitate was recovered by filtration, washed with acetone (3 × 100 mL) and driedto constant weight (17.9 g) in a vacuum drying box in the presence of P2O5 and KOH.Direct-phase TLC (eluent B) and reversed-phase HPLC (ACN/H2O gradient elution)analysis revealed that the precipitate contained unreacted α-CD (1, Rf = 0.15),monoazido-α-CD (7, Rf = 0.35) and diazido-α-CD (4, Rf = 0.45). The diazido-α-CDfraction was isolated by direct column chromatography. One-third of the precipitatewas dissolved in ACN/water/NH3 (25%) 10:7:1 (40 mL) and injected to thechromatographic column (310 g). After chromatographic separation of all threeportions of the crude mixture using mobile phase ACN/water/NH3 (25%) 10:5:1, the6A,6X-diazido-α-CD 4 (1.26 g, 5% yield) was obtained as a white solid material. 6A-Azido-α-CD 7 was also obtained as a white solid (3.69 g, 15% yield) as the secondeluted compound. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
91% | With tetraethylammonium chloride; 4-pyrrolidin-1-ylpyridine; ethanaminium,N-(difluoro-λ4-sulfanylidene)-N-ethyl-,tetrafluoroborate In N,N-dimethyl-formamide at 20℃; regioselective reaction; | Per(6-deoxy-6-halo)cyclodextrins 2; General Procedure General procedure: To a solution of freshly dried cyclodextrin 1 (2 mmol) in anhydrous DMF (40 mL) were added XtalFluor-E (2 equiv per glucose unit),4-(1-pyrrolidino)pyridine (1 equiv per glucose unit) and an anhydrous tetraethylammonium halide (2 equiv per glucose unit) with stirring at r.t. After the reaction was complete, as monitored by TLC, DMF was removed under reduced pressure and the resulting residue was poured into sat. Na2CO3 solution (50 mL); the reaction mixture was stirred for another 1 h. Addition of cold acetone (200mL) gave a precipitate which was collected by filtration and exhaustively washed with H2O and acetone to afford 2 as a white or pale brown solid. |
90% | With methanesulfonyl chloride In N,N-dimethyl-formamide at 65℃; for 48h; | |
80% | With methanesulfonyl chloride In N,N-dimethyl-formamide at 65℃; for 48h; |
With chloromethylenemorpholinium chloride; sodium methylate 1.) DMF, 60 deg C, 20 h, 2.) methanol; Yield given. Multistep reaction; | ||
With methanesulfonyl chloride In N,N-dimethyl-formamide at 65℃; for 48h; | ||
With methanesulfonyl chloride In N,N-dimethyl-formamide at 75℃; for 4.5h; Inert atmosphere; | ||
With methanesulfonyl chloride In N,N-dimethyl-formamide at 65℃; | ||
Stage #1: alpha cyclodextrin With Vilsmeier reagent In N,N-dimethyl-formamide at 70℃; for 4h; Stage #2: With water at 40℃; for 6h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With methanol; sodium azide; carbon tetrabromide; triphenylphosphine 1.) DMF, room temperature, 24 h; Yield given. Multistep reaction; | ||
Multi-step reaction with 2 steps 1: pyridine 2: sodium azide / H2O | ||
Multi-step reaction with 2 steps 1: 2.1 g / pyridine / 5 h / Ambient temperature 2: 3.08 g / sodium azide / H2O / 5 h / 80 °C |
Multi-step reaction with 2 steps 2: sodium azide / N,N-dimethyl-formamide / 140 °C | ||
Multi-step reaction with 2 steps 1.1: sodium hydroxide / water / 0.17 h 1.2: 2.33 h / 20 °C 2.1: sodium azide / water / 12 h / 80 °C | ||
Multi-step reaction with 2 steps 1: pyridine / 0.08 h / 20 °C 2: sodium azide / water / 16 h / 80 °C | ||
18.4 mg | Stage #1: alpha cyclodextrin With pyridine; p-toluenesulfonyl chloride at 0 - 20℃; for 23h; Molecular sieve; Stage #2: With sodium azide In N,N-dimethyl-formamide at 90℃; for 22h; | 6-NH2-a-CD -1V209 (8) To a suspension of a-cyclodextrin (360 mg, 0.370 mmol) and MS3A in anhydrous pyridine (35 mL) was added dropwise a solution of p-toluenesulfonyl chloride (64.3 mg, 0.34 mmol) in anhydrous pyridine (6 mL) at 0 °C. The mixture was stirred and warmed to room temperature. After stirring for 23 h, the mixture was filtered through Celite pad, concentrated in vacuo, and azeotroped with toluene. Obtained white solid was then dissolved in DMF (10 mL) and NaN3 (34.5 mg, 0.531 mmol) was added, and the mixture was stirred at 90 °C for 22 h. After concentration of the reaction mixture, the residue was purified by ODS column chromatography (H2O/methanol) to give mono azido a-CD as a white solid (18.4 mg, 5%, 2 steps). HRMS (positive mode) Found: m/z 1020.3126 [(M+Na)+], calculated for C36H59N3NaO29: 1020.3126. To a solution of mono azido a-CD (16.7 mg, 16.8 mmol) in H2O (3 mL) was added 10% Pd/C (16.9 mg). The reaction mixture was stirred at room temperature for 16 h under H2 atmosphere. After removal of insoluble materials by membrane filtration, the filtrate was concentrated in vacuo. Obtained mono amino a-CD was then dissolved in DMF/H2O (1:1, 1 mL) and a solution of 1V209 (6.40 mg, 17.8 mmol) in anhydrous DMF (0.5 mL), HATU (16.5 mg, 43.4 mmol), and TEA (5 μL, 35.9 mmol) were added. The mixture was stirred at room temperature for 26 h. The reaction was quenched by addition of H2O and the mixture was concentrated in vacuo. The residue was purified by ODS column chromatography (H2O/methanol) and preparative HPLC (eluent; 40% methanol in H2O) to give compound 8 as a white solid (6.0 mg, 27%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92% | In N,N-dimethyl-formamide at 50℃; for 48h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | In pyridine | |
100% | With iodine at 20℃; for 24h; neat (no solvent); | |
100% | With pyridine at 60℃; for 12h; |
100% | With pyridine at 60℃; for 12h; | |
94% | With iron(III) chloride hexahydrate | |
90% | With sodium hydrogencarbonate In N,N-dimethyl-formamide at 20 - 80℃; for 29h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With hydrogen In methanol; water at 20℃; for 12h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
5.3% | Stage #1: anthracen-9-carboxylic acid; alpha cyclodextrin; poly(ethylene glycol), Mw 3.35E3 Da In water at 20℃; Stage #2: With anthracen-9-carboxylic acid; benzotriazol-1-ol; triethylamine In water; N,N-dimethyl-formamide |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
0.3% | Stage #1: anthracen-9-carboxylic acid; alpha cyclodextrin; poly(ethylene glycol), Mw 2E3 Da In water at 20℃; Stage #2: With anthracen-9-carboxylic acid; benzotriazol-1-ol; triethylamine In water; N,N-dimethyl-formamide |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
99% | With sodium hydride In dimethyl sulfoxide at 20℃; for 22h; Inert atmosphere; Schlenk technique; | |
98% | In dimethyl sulfoxide at 20℃; Inert atmosphere; | |
95% | With sodium hydride In dimethyl sulfoxide at 20℃; for 18h; |
95% | With sodium hydride In dimethyl sulfoxide | |
94% | With sodium hydride In dimethyl sulfoxide at 20℃; for 18h; | |
91% | With sodium hydride In dimethyl sulfoxide at 20℃; | |
90% | With sodium hydride; dimethyl sulfoxide at 20℃; for 12h; | |
89% | With sodium hydride In dimethyl sulfoxide at 20℃; | |
88% | Stage #1: alpha cyclodextrin With sodium hydride In dimethyl sulfoxide; mineral oil at 60℃; for 1h; Inert atmosphere; Stage #2: benzyl chloride In dimethyl sulfoxide; mineral oil at 20℃; Inert atmosphere; | |
With sodium hydride In dimethyl sulfoxide at 20℃; | ||
With sodium hydride In dimethyl sulfoxide at 20℃; for 18h; | ||
With sodium hydride |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
66% | With sodium cyanide; lithium carbonate In water at 85℃; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
27% | Stage #1: alpha cyclodextrin; azobenzene-4,4'-dicarboxylic acid In sodium sesquicarbonate at 20℃; for 2h; Stage #2: 3,5-dimethylaminoaniline With 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride In sodium sesquicarbonate at 20℃; for 10h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: alpha cyclodextrin With pectin In water at 4.5 - 48℃; for 0.5h; Stage #2: dimethylglyoxal In water at 4.5℃; for 44h; | 2 The β-cyclodextrin of example 1 was replaced with α-cyclodextrin and dry blended with 1 wt % pectin (i.e., 1 wt % of pectin: β-cyclodextrin; XPQ EMP 5 beet pectin available from Degussa-France). The mixture was processed and dried by the method set forth in Example 1. The percent retention of diacetyl in the cyclodextrin inclusion complex was 11.4 wt %. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With pyridine In chloroform at 0 - 20℃; for 24.5h; Inert atmosphere; | ||
With pyridine In chloroform at 0 - 20℃; for 24.5h; Inert atmosphere; | 3 Synthesis of the Bromobutyryloxy α-Cyclodextrin (α-CD-BIBB) 2.3 Synthesis of the Bromobutyryloxy α-Cyclodextrin (α-CD-BIBB) A 250 mL round-bottom three-necked flask with a magnetic stirrer was charged with 6.48 g α-CD (6.67 mmol) and kept under nitrogen before the addition of 120 mL of dry pyridine. The system was cooled to 0 °C under stirring. A solution of 1.0 mL (8 mmol) 2-bromo-isobutyryl bromide (BIBB) in 40 mL of CHCl3 was slowly added within 30 min. Then, the reaction was continued at room temperature for 24 h. The mixture were washed with ice water several times to remove salts. And the organic layers were dried over anhydrous magnesium sulphate. The obtained white solids was washed with small amount of ice water again until the pH value reaches 7.0, then dried under vacuum at 40 °C to obtain α-CD-BIBB as white solids. FTIR (KBr pellet, cm-1): 1741 (-O-C=O), 3363 (O-H), 1366, 1332 (-C-CH3), 2930, 1407 (-CH2-), 630 (-Br). 1H NMR (D2O, ppm): 4.89-4.90 (6H, d, -CH(O-)2), 3.41-3.83 (42H, -OH, =CHO-, -CH2O-), 1.72 (6H, -CH3). Element analysis: theoretical value: C 42.83%, H 5.84%, Br 7.12%; Found: C 42.96%, H 5.99%. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
27% | Stage #1: alpha cyclodextrin With lithium hydride In dimethyl sulfoxide for 24h; Inert atmosphere; Stage #2: allyl bromide With lithium iodide In dimethyl sulfoxide for 2h; Inert atmosphere; Stage #3: acetic anhydride With triethylamine at 80℃; | 4.2.1. Per-O-acetyl-2I-O-allyl-α-cyclodextrin (3a) Firstly, the synthesis was carried out according to the exactly the same reaction conditions as described by Hanessian et al.refPreviewPlaceHolder10 The results were the same as described below, but the procedure was inconvenient. Thus the procedure was improved as follows: Dried α-cyclodextrin (880 mg, 910 μmol) was dissolved in dry DMSO (9 mL), and lithium hydride was added (11 mg, 1.4 mmol). The reaction mixture was stirred under an Ar atmosphere for 24 h. Then allyl bromide (79 μL, 910 μmol) and lithium iodide (3 mg, 24 μmol) were added to the reaction mixture. The reaction was monitored by TLC (6:3:1:1 1-PrOH-H2O-EtOAc-aq NH3) and was determined finished after 2 h when no significant increase in monosubstituted derivatives was observed. The CD derivatives were precipitated with acetone (170 mL), filtered out, and washed with acetone (50 mL). The precipitate was adsorbed on silica gel (3.5 g), and mono-O-allyl-α-CDs were separated by chromatography on a silica gel column (7:3:2 1-PrOH-H2O-EtOAc-aq NH3). The mixture of mono-O-allyl-α-CDs was then peracetylated. A suspension of mono-O-allyl-α-CDs in Ac2O (2.2 mL, 24 mmol) and Et3N (2.2 mL, 16 mmol) was stirred at 80 °C overnight. The reaction mixture was diluted with CHCl3, washed with 5% HCl, and the organic layer was evaporated in vacuo to give a brown residue that was purified by chromatography on silica gel (100:1 CHCl3-MeOH). Workup afforded 420 mg (27% overall yield based on α-CD) of the title compound as a white powder: mp 139-141 °C. +98 (CHCl3). IR (KBr): ν = 1747, 1372, 1238, 1040 cm-1. 1H NMR (300 MHz, CDCl3): δ 5.81 (ddt, 1H, J2',3'a 17.1, J2',3'b 10.4, J2',1' 5.7 Hz, H-2'), 5.73 (dd, 1H, J2,3 10.2, J3,4 8.9 Hz, H-3), 5.64 (dd, 1H, J2,3 10.6, J3,4 9.0 Hz, H-3), 5.59 (dd, 1H, J2,3 10.3, J3,4 8.7 Hz, H-3), 5.50 (dd, 1H, J2,3 10.1, J3,4 8.7 Hz, H-3), 5.46 (dd, 1H, J2,3 10.2, J3,4 8.7 Hz, H-3), 5.32 (dd, 1H, J2,3 9.8, J3,4 9.1 Hz, H-3I), 5.24 (dq, 1H, J2',3'a 17.2, J1',3'a = J3'a,3'b 1.5 Hz, H-3'a), 5.19 (dq, 1H, J2',3'b 10.3, J1',3'b = Jgem 1.2 Hz, H-3'b), 5.14 (d, 1H, J1,2 3.5 Hz, H-1), 5.11 (d, 1H, J1,2 3.6 Hz, H-1), 5.09 (d, 1H, J1,2 3.8 Hz, H-1), 4.99 (d, 1H, J1,2 2.9 Hz, H-1), 4.99 (d, 1H, J1,2 3.1 Hz, H-1), 4.87 (d, 1H, J1,2 3.2 Hz, H-1I), 4.82 (dd, 1H, J2,3 10.3, J1,2 3.9 Hz, H-2), 4.81 (dd, 1H, J2,3 10.7, J1,2 3.7 Hz, H-2), 4.77 (dd, 1H, J2,3 10.4, J1,2 3.6 Hz, H-2), 4.77 (dd, 1H, J2,3 10.2, J1,2 3.5 Hz, H-2), 4.71 (dd, 1H, J2,3 10.2, J1,2 3.8 Hz, H-2), 4.60-4.05 (m, 18H, 6 × H-5, 12 × H-6), 4.03-3.99 (m, 2H, 2 × H-1'), 3.85-3.77 (m, 4H, 4 × H-4), 3.74 (t, 1H, J3,4 = J4,5 9.2 Hz, H-4), 3.66 (t, 1H, J3,4 = J4,5 9.2 Hz, H-4I), 3.32 (dd, 1H, J2,3 10.1, J2,3 3.1 Hz, H-2I), 2.30-1.98 (m, 51H, 17 × CH3). 13C NMR (101 MHz, CDCl3): δ 170.90-169.01 (17 × CO), 134.46 (C-2'), 117.76 (C-3'), 98.68 (C-1I), 97.19 (C-1), 96.70 (C-1), 96.58 (C-1), 96.38 (C-1), 95.82 (C-1), 79.58-68.73 (5 × C-2, 5 × C-3, 5 × C-4, 6 × C-5), 78.06 (C-4I), 77.96 (C-2I), 72.87 (C-3I), 72.13 (C-1'), 63.40-62.89 (6 × C-6), 20.94-20.62 (17 × CH3). HRESIMS: [M+Na]+, found 1749.5146. C73H98O47Na requires 1749.5171. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
40% | With barium hydroxide octahydrate; barium(II) oxide In dimethyl sulfoxide; N,N-dimethyl-formamide at 20℃; for 120h; Inert atmosphere; | 4.3. Cyclohexakis-(1→4)-2,6-di-O-allyl-α-d-glucopyranosyl [per(2,6-di-O-allyl)-α-cyclodextrin] The compound was prepared from α-cyclodextrin (3 g, 3.1 mmol), using the procedure described for 4β. Column chromatography (SiO2, 40:60 EtOAc-CHCl3) afforded a white solid (1.8 g, 40%) that was characterized as per(2,6-di-O-allyl)-α-cyclodextrin (α). 1H NMR (300 MHz, DMSO-d6): δ 5.81-5.96 (m, 12Hb), 5.11-5.34 (m, 24Hc), 4.95 (d, 6H1), 4.56 (s, 6OH3), 3.30-4.35 (m, 24Ha, 6H5, 6H3, 6H6, 6H4, 6H2); 13C NMR (75 MHz, CDCl3): δ 68.82 (C6), 70.40 (C5), 73.68 (C3), 72.65, 73.24 (Ca), 78.65 (C2), 83.52 (C4), 101.50 (C1), 117.37, 118.75 (Cc), 134.23, 134.85 (Cb); ESIMS: m/z 749.5 (M+2Na)2+, 1476.4 (M+Na)+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In methanol; aq. phosphate buffer; at 24.99℃;pH 7.2; | General procedure: The inclusion complex formation phenomenon of CDs with guest DIMs in aqueous phosphate buffer solutions was examined at pH 7.2 by means of UV?visible spectral titration in a Shimadzu 1700 Spectrophotometer (Shimadzu Corporation, Kyoto, Japan). A 1.0 mM stock solution of DIMs (5.0 ml) was prepared in methanol, and 6.0 ll of this stock solution was added to the phosphate buffer solution to maintain the final concentration of molecules as 2.5 10 7 mol dm 3 in the cuvette. Then gradually a-, b-, c-CD were added in the cuvette so that the concentrations of CDs ranged from 0 to 12.5 10 3 mol dm 3. The absorption spectra were measured against an appropriate reagent blank. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In water |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
83% | With pyridine at 0℃; for 2h; | 4.1.1 Per-6-O-dimethylthexylsilyl-α-CD (3) General procedure: To a solution of anhydrous α-CD 1 (5.0g, 5.14mmol) in dry pyridine (300mL) at 0°C wasadded dropwise dimethylthexylsilyl chloride (13.34mL, 67.8mmol). The mixture was stirred for 2h at 0°C, and then allowed to room temperature. The reaction was monitored by TLC (butanone-1-butanol-water, 9:1:1; Rf 0.50), and it was completed after 40h. Solvent was evaporated under reduced pressure, a solution of the residue in chloroform (250mL) was washed with water and dried, and the solvent was evaporated. The residue was recrystallized from MeOH-CHCl3 to give 3 (7.85g, 83% yield). 1H NMR (400MHz, CDCl3): δ 6.53 (s, 6H, 6× OH), 5.30 (s, 6H, 6× OH), 4.89 (d, 6H, J=3.0Hz, 6× H-1), 4.04 (dd, 6H, J=8.9, 9.0Hz, 6× H-3), 3.92 (dd, 6H, J=2.7, 11.4Hz, 6× H-6a), 3.81 (m, 6H, 6× H-5), 3.92 (dd, 6H, J=∼1.0, 10.8Hz, 6× H-6b), 3.64 (m, 12H, 6× H-2+6× H-4), 1.62 (septet, 6H, J=6.8Hz, 6× (CH3)2CHC(CH3)2Si), 0.90-0.85 (4× s, 72H, 6× (CH3)2CHC(CH3)2Si+6× (CH3)2CHC(CH3)2Si), 0.09 (m, 36H, 6× (CH3)2Si). 13C NMR (100MHz, CDCl3): δ 101.4 (6× C-1), 81.4 (6× C-2), 74.4 (6× C-3), 73.1 (6× C-5), 72.3 (6× C-4), 61.6 (6× C-6), 34.2 (6× (CH3)2CHC(CH3)2Si), 25.2 (6× (CH3)2CHC(CH3)2Si), 20.4, 20.3, 18.6, 18.5 (6× (CH3)2CHC(CH3)2Si+6× (CH3)2CHC(CH3)2Si), -3.26, -3.3 (6× (CH3)2Si). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With sodium hypophosphite monohydrate at 140℃; for 0.5h; | Synthesis of poly-(cyclo)dextrins General procedure: Water soluble polymers of MD, α-CD, β-CD, γ-CD, HPβCD and MβCD, respectively named polyCTR-MD, polyCTR-αCD, polyCTR-βCD, polyCTR-γCD, polyCTR-HPβCD and polyCTR-MβCD, were synthesized as previously reported (Martel et al., 2002; Martel, Ruffin, Weltrowski, Lekchiri, & Morcellet, 2005). Briefly, aqueous solutions (200 mL) of sodium dihydrogen hypophosphite (30 g/L), CTR (100 g/L) and the corresponding CD or MD (100 g/L) were prepared under stirring at room temperature. Water was totally removed from the solutions using a Rotavapor (Büchi, Switzerland). The resulting dried mixture was then heated at 140 °C in oil bath during 30 min also under vacuum (∼60 mbar). The polymer was redispersed in water (200 ml) and then filtered on sintered glass funnel to remove the insoluble fraction. The filtrate was concentrated in rotavapor and dialyzed (6000-8000 MWCO) against water (2 L, exchanged every 12 h) for 3 days. Finally, the polymer was recovered as a white powder by freeze-drying. The yield of each polymer fraction (soluble and gel) was calculated as the ratio of the weight of the obtained product to the weight of CTR plus CD in the initial solution. The catalyst was neglected as only traces of phosphorus were detected by elemental analysis in the final product |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
78.5% | Stage #1: alpha cyclodextrin In water at 55℃; Inert atmosphere; Cooling with ice; Stage #2: D,L-sulforaphane In water at 20℃; for 16h; | 2 a-Cyclodextrin (Wacker CAVAMAX W6 Food Grade, 3015g, 3.1 moles, 1 equivalent) was dissolved in distilled water (8L) by heating up to 55°C under nitrogen atmosphere. Thehomogeneous solution was cooled down to - 25°C using an ice-water bath and then degassed for-20 min by purging nitrogen. After degassing, it turned into a foggy solution. Aqueous solutionof sulforaphane was removed from the refrigerator (see previous step) and then added to theabove foggy a-cyclodextrin solution at once. At this stage reaction temperature was -18°C, and continued stirring at room temperature overnight ( -16h). The heterogeneous reaction mixturewas cooled down to 1-2 °C using ice-methanol bath and stirred for 3 hr at that temperature. Theprecipitated white solid was filtered and dried overnight under high vacuum at room temperatureby covering the filter funnel with a latex sheet. The white filter cake was transferred into a 10-Lrotovap flask and dried further at room temperature under a high vacuum to afford 2,802g of complex (98.7% pure by HPLC, 78.5% yield). All three batches were conducted at almost same scale and the reactions proceeded in similar way in terms of reaction time, yield, product purity and percentage loading ofsulforaphane on a-cyclodextrin 1HNMR (D20, 400 MHz); 81.99 (br, 4H), 2.73 (s, 3H), 2.98 (br, 2H), 3.60 (m, 12H), 3.70(br, 2H), 3.92(m, 24H), 5.11 (d, 6H). 13 CNMR (D20, 100 MHz); u~ 130.05, 101.82, 81.40, 74.05, 71.98, 71.84, 60.34, 52.02,44.94, 37.03, 29.29, 20.08..11 (d, 6H). |
76.9% | With dihydrogen peroxide In water at 0 - 55℃; Large scale; | 1; 1A; 4 Example 1A: Formation of a complex of sulforaphane and α-cyclodextrin according to procedures in WO 2013/179057 To degassed a-cydodextrin (30 g, 0.01 eqv) in water (1 L) at room temperature was added 1-isothiocyanato-4-methylthiobutane (501 g, 1 eqv). The solution was cooled to 0°C and degassed for 30 mins. To the suspension was added 35% aqueous H2O2 (305 mi, 1 eqv) slowly while maintaining the internal temp below 4°C during the addition. The reaction mixture was stirred for 8 hr at ice bath temperature and was then allowed to warm to room temperature while stirring overnight. The solution was filtered to remove solids. The filtrate was refrigerated for 5 hr prior to use in the next step. α-cyclodextrin (3015 g, 1 eqv) was dissolved in water (8 L) by heating up to 55 °C, The solution was cooled down to room temperature and the sulforaphane filtrate from the previous step was added at once. The mixture was stirred at room temperature overnight. The reaction mixture was then cooled in an ice bath and stirred at that temperature for 3 hr. The precipitated solid was filtered through Buchner funnel and dried on the filter under vacuum overnight. The filter cake was transferred to a 10 L round-bottomed flask and dried under high vacuum at room temperature over the weekend to yield a white soiid (2.74 kg, 76.9% yieid; batch ref. 191PAL79). The soiid had a water content of 11.3% w/w by Karl-Fischer analysis and a purity by HPLC of 98.5%. 1-NMR analysis confirmed that Example 1A was a 1:1 sulforaphane:α-cyclodextrin complex. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In methanol; water; at 50℃; | General procedure: CD (1 mmol) was dissolved in 30 ml distilled water and SMP (1 mmol) in 20 ml methanol and was slowly added to the CD solution. This solution was stirred at 50 C overnight. The above solution was refrigerated overnight at 5 C. The precipitated SMP/CD complexes were recovered by filtration and washed with a small amount of ethanol and water to remove uncomplexed drug and CD, respectively. This precipitate was dried in vacuum at room temperature for two days and stored in an air tight bottle. This powder sample was used for further analysis. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In methanol; water; at 50℃; for 24h; | General procedure: alpha-CD/beta-CD (0.9728/1.135g) was dissolved in 40ml distilled water at 50C in a water bath. SMRZ (0.264g) in 10ml methanol was slowly added to the CD solution with continuous agitation. The molar ratio of SMRZ to CDs was 1:1. The vessel covered with aluminum foil and stirred continuously for 24h. Then the final solution was refrigerated overnight at 5C. The precipitated SMRZ/CDs complexes were recovered by filtration and washed with small amount of methanol and water to remove uncomplexed drug and CDs, respectively. This precipitate was dried in vacuum at room temperature for two days and stored in an airtight bottle. This powder samples were further analyzed by using FT-IR,1H NMR, DSC, XRD and SEM methods. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In methanol; water at 50℃; | Preparation of Nanomaterials General procedure: CD (1mmol) was dissolved in 40 mL of distilled water and DHAB or HAB (1 mmol) in 10 mL of methanol and was slowly added to the CD solution. This mixture was stirred at 50 °C overnight. Then the final solution was refrigerated overnight at 5 °C. The precipitated DHAB/CD and HAB/CD complexes were recovered by filtration and washed with a small amount of ethanol and water to remove uncomplexed DHAB, HAB, and CD, respectively. This precipitate was dried in vacuum at room temperature for two days and stored in an airtight bottle. This powder sample was used for further analysis. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With cyclodextrin glucanotransferase; In aq. buffer; for 24h;pH 5.4; | Production Example 1 400 mg of trans-resveratrol-3-O-beta-D-monoglucoside, 4 g of alpha-cyclodextrin, and 25 mL of Cyclodextrin glucanotransferase ?Amano? (600 units/mL; Amano Enzyme Inc.) were added to 300 mL of citric acid-sodium citrate buffer (pH of 5.4), and the mixture was stirred by a magnetic stirrer in a hot-water bath at 55 C. for 24 hours to perform enzyme reaction. [0133] Subsequently, the reaction solution was heated to 80 C. in a hot-water bath to inactivate the Cyclodextrin glucanotransferase ?Amano?. The reaction solution was then cooled to ordinary temperature, and partition extraction with ethyl acetate/water was performed six times. The obtained oil phase fraction was subjected to salting-out, dehydration, and a vacuum concentration process, and sampled by HPLC using a CrestPak C18S column (JASCO; 4.6×150). [0134] The aqueous phase fraction obtained by partition extraction with ethyl acetate was further subjected to partition extraction with water-saturated n-butanol three times, and then to a vacuum concentration process. Subsequently, fractionation was performed by HPLC using a CrestPak C18S column (JASCO; 4.6×150), and each fraction was sampled. The HPLC was performed for 40 minutes under the following conditions: column temperature: 40 C., mobile phase: a mixture of acetonitrile and water (15:85), flow rate: 1.0 m/min, and injection amount: 5 muL. [0135] FIG. 1 shows the results of column chromatography by HPLC of the reactant obtained by using trans-resveratrol-3-O-beta-D-monoglucoside as a starting material. FIG. 1 (A) is the column chromatogram of the oil phase fraction after phase separation with ethyl acetate/water, and (B) is the column chromatogram of the aqueous phase fraction. [0136] As shown in FIG. 1 (A), only a single peak was obtained from the oil phase fraction, whereas (B) shows that prominent peaks, which indicated that sugar units were added to the trans-resveratrol-3-monoglucoside to produce polysaccharides with 2 to 5 sugars, were detected on the basis of the difference in retention time by HPLC (fractions indicated by (a) to (d)). Further, the production of polysaccharides with 6 to 9 sugars was also detected (fraction (e)). [0137] The fraction (a), which showed the longest retention time (horizontal axis of the graph) in the column chromatogram by HPLC of the oil phase fraction, was subjected to NMR measurement. The frequency of the apparatus used was 400 MHz. FIG. 2 shows the results. [0138] From the results shown in FIG. 2 (A), this fraction was identified as trans-resveratrol-3-O-beta-D-diglucoside shown in (B). These results also suggested that the fraction showing a single peak in FIG. 1 (A) was trans-resveratrol-3-O-beta-D-monoglucoside, which was a starting material. [0139] Further, the fraction (a) and the fraction (b), which showed the second-longest retention time, were combined and subjected to MS measurement. FIG. 5 shows the results. The obtained results matched the molecular weights of trans-resveratrol-3-O-beta-D-diglucoside and a polysaccharide in which two molecules of glucose were added to trans-resveratrol-3-O-beta-D-monoglucoside. [0140] FIG. 6 shows the results when the fractions (c) and (d) were similarly subjected to MS measurement. The obtained results of these fractions matched the molecular weights of a polysaccharide in which three molecules of glucose were added to trans-resveratrol-3-O-beta-D-monoglucoside, and a polysaccharide in which four molecules of glucose were added to trans-resveratrol-3-O-beta-D-monoglucoside. [0141] The above results revealed that although trans-resveratrol monoglucoside was not dissolved in water at ordinary temperature, polysaccharides in which one or more glucose molecules were further added to trans-resveratrol monoglucoside (e.g., trans-resveratrol-3-O-beta-D-diglucoside), etc., could acquire water solubility at ordinary temperature. [0142] FIG. 7 is a photographic image showing trans-resveratrol-3-O-beta-D-monoglucoside contained in the fraction showing a single peak detected in FIG. 1 (A), and trans-resveratrol-3-O-beta-D-diglucoside contained in the fraction (a) in FIG. 1 (B), after they were dissolved in distilled water and allowed to stand at room temperature. [0143] As is clear from the figure, the tube of the trans-resveratrol-3-O-beta-D-monoglucoside was turbid (on the right side of the photographic image), indicating that it was not dissolved in distilled water at room temperature, whereas the tube of the trans-resveratrol-3-O-beta-D-diglucoside was transparent (on the left side of the photographic image), indicating that it was easily dissolved in distilled water at room temperature. [0144] The retention time of cis-resveratrol by column chromatography is known to tend to be longer than that of trans-resveratrol; however, the results of the above chromatogram showed no detection of cis-resveratrol. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
30% | Stage #1: alpha cyclodextrin With lithium hydride In dimethyl sulfoxide Stage #2: propargyl bromide With lithium iodide In dimethyl sulfoxide at 55℃; Darkness; | Mono-2-propargyl-β-CD General procedure: To a solution of dry β-CD (10g, 10 mmol) in DMSO (100 ml) LiH (1 eq) was added and stirred overnight, until solution became clear. Next, propargyl bromide (1 eq) and LiI (spatula point) were added and the mixture was stirred at 55 °C for 5h, avoiding light exposition. Solvent was evaporated under reduced pressure, resulting slurry was dissolved in water (20 ml) and precipitated with acetone (500 ml). Solid residue was filtered, air-dried and resulting powder was dissolved in water and passed through styrene resin (Diaion HP-20) using gradient of water/methanol (0 to 10%) as solvent. Prior to use,resin was conditioned in methanol for 1 h and rinsed with water. Fractions containing pure product were evaporated under reduced pressure giving 4,1g of 4. The analytical data were in accord with literature values (Casas-Solvas,J.; Ortiz-Salmcron, E.; Fernandez, I.;Garcia-Fuentes, L.; Santoyo-Gonzales, F.; Vargas-Berenguel, A. Chem. DM J. 2009, 15,8146- 8162) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In water |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
1: 14% 2: 17% | With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; | γ-cyclodextrin conjugates 18 and 19. 4-(2-(4-((6-Cyclohexyl-[1,2,4]triazolo[1,5-a]pyrazin-8-yl)amino)-1H-pyrazol-1-yl)ethoxy)-4-oxobutanoic acid (460 mg, 1.08 mmol), EDC (289mg, 1.51 mmol), γ-cyclodextrin (2.79 g, 2.152 mmol) and DMAP (26.3 mg, 0.215 mmol) were combined. DMF (3.0 mL) was added and the reaction mixture was stirred at ambient temperature overnight. Acetone (20 mL) was added to the reaction mixture and the resultingsuspension was filtered and rinsed with additional acetone (2 x 10 mL). The collected solid waspurified via HPLC-MS to yield two products as white solids, 2-O-γ-cyclodextrin conjugate 18(258 mg, 14%); MS m/z: 1707 (M+H)+ 1H NMR (400 MHz, DMSO-d6) δ 10.14 (s, 1H), 8.47 (s,1H), 8.15 (s, 1H), 8.04 (s, 1H), 7.92 (s, 1H), 6.06±5.36 (m, 16H), 5.13 (d, J = 3.8 Hz, 1H), 4.95±4.78 (m, 7H), 4.74±4.39 (m, 8H), 4.36 (s, 4H), 3.84±3.75 (m, 1H), 3.70±3.43 (m, 30H), 3.44±3.11 (m, 16H), 2.74±2.51 (m, 5H), 1.92 (d, J = 11.9 Hz, 2H), 1.82 (d, J = 12.6 Hz, 2H), 1.73 (d,J = 12.1 Hz, 1H), 1.65±1.51 (m, 2H), 1.39 (q, J = 12.5 Hz, 2H), 1.32±1.20 (m, 1H). 6-O-γ-cyclodextrinconjugate 19 (315 mg, 17%); MS m/z: 1707 (M+H)+. 1H NMR (400 MHz, DMSO-d6) δ10.13 (s, 1H), 8.47 (s, 1H), 8.15 (s, 1H), 8.03 (s, 1H), 7.90 (s, 1H), 5.75 (br s, 16H), 4.89±4.84(m, 8H), 4.46 (br s, 8H), 4.35 (s, 4H), 4.31±4.16 (m, 2H), 4.15±4.07 (m, 1H), 3.84±3.72 (m,1H), 3.70±3.44 (m, 29H), 3.41±3.30 (m, 14H), 2.63±2.50 (m, 5H), 1.92 (d, J = 12.0 Hz, 2H),1.82 (d, J = 12.8 Hz, 2H), 1.73 (d, J = 12.4 Hz, 1H), 1.68±1.50 (m, 2H), 1.38 (q, J = 12.6 Hz, 2H),1.32±1.22 (m, 1H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
23% | With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; for 17h; | α-cyclodextrin conjugate 20 4-((4-(4-((6-Cyclohexyl-[1,2,4]triazolo[1,5-a]pyrazin-8-yl)amino)-1H-pyrazol-1-yl)-2-methylbutan-2-yl)oxy)-4-oxobutanoic acid (0.200 g, 0.426 mmol),α-cyclodextrin (0.829 g, 0.852 mmol) and N,N-dimethylpyridin-4-amine (10.4 mg, 0.085mmol) were combined with DMF (4.0 mL). EDC (0.122 g, 0.639 mmol) was added and there action mixture was stirred at ambient temperature for 17 h. Acetone (5 mL) was added andthe resultant precipitate was filtered. The collected solid was purified by HPLC-MS to providethe α-cyclodextrin conjugate 20 (0.140 g, 23%); MS m/z: 1425 (M+H)+. 1H NMR (400 MHz,DMSO-d6) δ 10.11 (s, 1H), 8.47 (s, 1H), 8.18 (s, 1H), 8.15 (s, 1H), 8.04 (s, 1H), 7.83 (s, 1H),5.60±5.34 (m, 12H), 4.84±4.74 (m, 7H), 4.45 (br s, 5H), 4.34±4.27 (m, 1H), 4.25 (s, 1H), 4.21±4.10 (m, 2H), 3.89±3.82 (m, 1H), 3.81±3.72 (m, 7H), 3.71±3.52 (m, 16H), 3.47±3.30 (m, 10H),2.69±2.57 (m, 1H), 2.55±2.49 (d, J = 6.7 Hz, 3H), 2.29±2.17 (m, 2H) δ 1.91 (d, J = 10.9 Hz, 2H),1.82 (d, J = 12.8 Hz, 2H), 1.73 (d, J = 12.2 Hz, 1H), 1.59 (q, J = 12.1, 10.9 Hz, 2H), 1.46±1.33(m, 8H), 1.32±1.18 (m, 1H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In water; at 80℃; for 4h; | General procedure: Aqueous CD solutions were prepared by adding the solidCD to water and ultrasonicating the mixture for 30 min.To obtain the ICs, the IL was added to the mixture, followedby heat treatment at 80 C in a water bath for 4 h andfinally 30 min of further ultrasonication. The concentrationsof CD and ILs in each aqueous IC solution are provided inTable 1. The ICs are named according to the constituent CDand IL: A and B refer to alpha- and beta-CD, respectively, whilethe number indicates the alkyl chain length of the cation ofthe IL. A separate gel-like phase was obtained for all fourICs (shown in Online Resource 1). In the case of B12, theIC phase precipitated out spontaneously during preparation.A4, A12, and B4 IC phases appeared several weeks afterpreparation. The IC phases were separated from the aqueoussolution and dried by heating to 80 C. While the IC phaseswere white/translucent in solution, they turned dark whenseparated from the solution and/or dried. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
64.67% | In ethanol; water at 25℃; for 72h; Darkness; | 2.3. Preparation of DALY/a-CD inclusion complex The inclusion complex was prepared using the suspensionmethod. DALY (0.02 mmol, 7.1 mg) and a-CD (0.01 mmol, 9.7 mg)were dissolved in 5mL solution (ethanol andwater, V: V 1:5), andthe resulting suspension was magnetically stirred at 25 C for 3days in dark place. Afterwards, the 0.45 mm pore size nylon membranesyringe filter was used to remove the uncomplexed DALYresidue. The filtrate was then evaporated under reduced pressureand dried in vacuum to acquire DALY/a-CD inclusion complex asthe final product (yields: 64.67%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
86% | In water; at 49.84 - 54.84℃; for 36.0h; | Both of the solid ICs (TgCl+alpha-CyD and TgCl+beta-CyD) were prepared in 1:1M ratios of TgCl and CyD. For each complex, 5.0mM of TgCl and 5.0mM of CyD were separately prepared in 10mL of water each and stirred for 4h. Then, the aqueous solution of TgCl was added dropwise to the aqueous solution of CyD. The resulting mixture was then stirred for 36hat 323-328K and filtered at this temperature. The mixture was then cooled to 278K and held at this temperature for 12h. The resulting solution was filtered to obtain a white powder, which was washed with water and ethanol respectively and dried in air. The yields of the solid inclusion complexes were 86% and 88% for TgCl+alpha-CyD and TgCl+beta-CyD respectively. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In aq. phosphate buffer; at 24.99℃; for 36h;pH 7.4;Thermodynamic data; | General procedure: Solubility of all the required compounds was specifically checked in triply distilled and de-ionized water. Mettler Toledo AG-285 having uncertainty±0.0003g was used to prepare all the solutions of THC, HSA, alpha-and beta-CD by mass at room temperature. All the stock solutions were prepared by mass dilution and freshly prepared solutions were used during each experiment in phosphate buffer aqueous solution of pH 7.4. Sufficient precautions had been taken during measuring weights, preparing solutions and performing all the respective experiments. Two solid ICs, THC+ alpha-CD and THC+beta-CD had been prepared in 1:1M ratio of THC and CD. 1.0mM of alpha-and beta-CD were each separately mixed with water and stirred for 4h. After that the aqueous solution of 1.0mM of THC was added dropwise to the respective solutions of CD and left for stirring near about 36h at 50-55C to prepare the corresponding two ICs. Just after filtration of the hot solutions, it is allowed to cool down to 5C and kept for 12h without any disturbing. The obtained suspension was then filtered and washed with ethanol and dried in air to get white polycrystalline powder. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In water; at 40 - 45℃; for 96.0h;Thermodynamic data; | General procedure: ICs (alpha-CD + CDP and beta-CD + CDP) were also preparedin the solid state taking 1:1 mol ratio of the drug CDP andeach CD. For this purpose 1.0 mmol CD was dissolved in20 mL water and 1.0 mmol drug CDP was dissolved in20 mL water. These two solutions are allowed to stir separatelyin a magnetic stirrer for 3 h. The aqueous solution ofthe drug was added dropwise into the aqueous solution ofthe cyclodextrin. Then the mixture is constantly stirred for4 days at 40-45 C. The solution was filtered at that temperature,then cooled to 5 C and kept for 24 h. The resultingsuspension was filtered and the white polycrystalline powderwas found, it was dried in air. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In water; at 49.99℃; | To prepare 1:1 a solid Inclusion Complex between AmbroxolHydrochloride and alphaCD as well as with betaCD, at first, 30 mg of solidguest compound of AMB (which is also pretty much soluble in hotwater) was taken in a beaker and amount 40 ml of distilled water was added to it and placing it in a thermostated water bath at temperatureset at 323.15 K with constant stirring in a magnetic stirrer. Next, accuratelymeasured 70.39 mg of alphaCD and 82.13 mg of betaCD were addedin solid form in two different beakers slowly in presence of the constantstirring. It was kept in the thermostated water bath for 24-48 h.Thereafter, it was collected and dried in a hot oven & after that inclusioncomplexes in the solid form were obtained. |
Tags: 10016-20-3 synthesis path| 10016-20-3 SDS| 10016-20-3 COA| 10016-20-3 purity| 10016-20-3 application| 10016-20-3 NMR| 10016-20-3 COA| 10016-20-3 structure
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :